Bioreference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
08/16/21, 1:58 PM
Location
Industry
medical
biotechnology
health care
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche.
Company Info
Location
Elmwood Park, New Jersey, United States
Company info
BioReference is at the center of progress for patient care, providing laboratory testing and clinical diagnostic services. It offers a comprehensive test menu and unparalleled expertise and client service to healthcare providers, hospitals, integrated delivery networks, and physician offices. BioReference is a wholly owned subsidiary of OPKO Health, Inc.